Analysis of Tuberculosis Meningitis Pathogenesis, Diagnosis, and Treatment

Area of Science:

• Neuroinfectious diseases
• Immunology
• Infectious disease pathogenesis

Background:

• Tuberculosis (TB) remains a global health challenge, with increasing incidence linked to multidrug-resistant strains and immunocompromised populations.
• Central nervous system TB, particularly TB meningitis (TBM), presents a diagnostic and therapeutic challenge, often leading to severe neurological sequelae or death if untreated.

Purpose of the Study:

• To review the latest biomedical research developments in TB meningitis.
• To focus on key areas including host immune responses, pathogenesis, diagnosis, and treatment strategies for TBM.

Main Methods:

• This is a review article, synthesizing recent findings from biomedical research.
• Literature search and analysis focusing on host immune responses, pathogenesis, diagnosis, and treatment of TBM.

Main Results:

• TBM progression involves distinct clinical phases, from initial malaise to severe neurological deficits.
• Delay in TBM treatment significantly increases mortality and neurological morbidity.
• Advances in understanding host immune responses and pathogenesis are crucial for improved diagnostics and therapeutics.

Conclusions:

• TBM is a critical manifestation of tuberculosis requiring prompt diagnosis and effective treatment.
• Continued research into host immunity, pathogenesis, and novel therapeutic approaches is essential to combat TBM and improve patient outcomes.